» Articles » PMID: 35871570

Vitamin K Intake and Risk of Lung Cancer: The Japan Collaborative Cohort Study

Overview
Journal J Epidemiol
Specialty Public Health
Date 2022 Jul 24
PMID 35871570
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Limited reports from prospective human studies investigated the possible role of vitamin K in the development of lung cancer although vitamin K's anticarcinogenic activities were verified from several in vitro and in vivo studies. We investigated the associations between total vitamin K intake from food and the development of lung cancer based on this large prospective cohort study.

Methods: A validated food frequency questionnaire was used to examine vitamin K intake among 42,166 (16,341 men and 25,825 women) at the Japan Collaborative Cohort Study's baseline (1988-1990). Hazard ratios (HRs) and 95% confidence intervals (CIs) of incident lung cancer were calculated using the Cox proportional hazard regression method based on vitamin K consumption quartiles.

Results: 430 cases (308 males and 122 women) of lung cancer were documented during a total of 564,127 person-years of follow-up (median follow-up, 14.6 years). Vitamin K consumption was shown to be inversely related to lung cancer risk; the multivariable hazard ratio [HR] for the highest versus lowest quartiles was 0.67 (95% confidence interval [CI], 0.46-0.96; P for trend = 0.010). This relationship appears to be stronger in males (HR 0.62; 95% CI, 0.40-0.96; P for trend = 0.016) than in females (HR 0.82; 95% CI, 0.42-1.61; P for trend = 0.39) (P for interaction = 0.012), and in ever smokers (HR 0.57; 95% CI, 0.36-0.91; P for trend = 0.006) than in never smokers (HR 0.79; 95% CI, 0.40-1.55; P for trend = 0.37) (P for interaction = 0.30). The individuals' age, body mass index, or alcohol consumption status had no effect on the observed connection.

Conclusion: Vitamin K consumption reduces the risk of lung cancer. More research is needed to clarify the molecular processes behind this connection.

Citing Articles

Vitamin K Properties in Stroke and Alzheimer's Disease: A Janus Bifrons in Protection and Prevention.

Grimaldi L, Cavallaro R, De Angelis D, Fuso A, Sancesario G Molecules. 2025; 30(5).

PMID: 40076254 PMC: 11901974. DOI: 10.3390/molecules30051027.


Disease burden of lung cancer attributable to metabolic and behavioral risks in China and globally from 1990 to 2021.

Li L, Zhang X, Jiang A, Guo X, Li G, Zhang M BMC Public Health. 2025; 25(1):911.

PMID: 40055772 PMC: 11887075. DOI: 10.1186/s12889-025-21941-y.

References
1.
Eshak E, Iso H, Yamagishi K, Cui R, Tamakoshi A . Dietary intakes of fat soluble vitamins as predictors of mortality from heart failure in a large prospective cohort study. Nutrition. 2018; 47:50-55. DOI: 10.1016/j.nut.2017.09.009. View

2.
Okano T, Shimomura Y, Yamane M, Suhara Y, Kamao M, Sugiura M . Conversion of phylloquinone (Vitamin K1) into menaquinone-4 (Vitamin K2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice. J Biol Chem. 2007; 283(17):11270-9. DOI: 10.1074/jbc.M702971200. View

3.
Takata Y, Xiang Y, Yang G, Li H, Gao J, Cai H . Intakes of fruits, vegetables, and related vitamins and lung cancer risk: results from the Shanghai Men's Health Study (2002-2009). Nutr Cancer. 2013; 65(1):51-61. PMC: 3787870. DOI: 10.1080/01635581.2013.741757. View

4.
Dasari S, Ali S, Zheng G, Chen A, Dontaraju V, Bosland M . Vitamin K and its analogs: Potential avenues for prostate cancer management. Oncotarget. 2017; 8(34):57782-57799. PMC: 5593683. DOI: 10.18632/oncotarget.17997. View

5.
Bade B, Dela Cruz C . Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2020; 41(1):1-24. DOI: 10.1016/j.ccm.2019.10.001. View